3D Bioprinting Market to Reach $2.4 Billion by 2029, Growing at a CAGR of 12.7%

March 23 19:29 2026
3D Bioprinting Market to Reach $2.4 Billion by 2029, Growing at a CAGR of 12.7%
3D Bioprinting Market by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM), Application (Research (Regenerative Medicine, 3D cell Culture), Clinical (Skin, Bone)) – Global Forecast to 2029.

According to MarketsandMarkets™, The report ” 3D Bioprinting Market by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM), Application(Research (Regenerative Medicine, 3D cell Culture), Clinical (Skin, Bone)) – Global Forecast to 2029″, is projected to reach USD 2.4 billion by 2029 from USD 1.3 billion in 2024, at a CAGR of 12.7% during the forecast period.

 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170201787

 

Browse

  • 530 Market Data Tables
  • 46 Figures
  • 453 Pages and in-depth TOC on “ 3D Bioprinting Market – Global Forecast to 2029”.

 

Some of the prominent key players are:

  • BICO Group AB (US),
  • Organovo Holdings Inc. (US),
  • Allevi, Inc. (part of 3D Systems, Inc.) (US),
  • CollPlant Biotechnologies Ltd. (Israel), and many more……

 

Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the 3D Bioprinting Market.

 

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170201787

  • Based on component, the global 3D bioprinting market is segmented into 3D bioprinters, bioinks, software and consumables. 3D bioprinters accounted for the larger market share in 2023. The segment is witnessing growth driven by technological innovations and escalating demand for organ transplantation services.
  • Based on application, the 3D bioprinting market is segmented into research applications and clinical applications. research applications segment accounted for the larger share of the 3D bioprinting market in 2023. The market for research applications is further segmented into drug research, regenerative medicine, and 3D cell culture.
  • The market is segmented into five major regions namely, North America, Europe, the Asia Pacific, Latin America, Middle East and Africa. In 2023, North America accounted for the largest share of the 3D bioprinting market and expected to retain dominance throughout the forecast period of 2024-2029.

 

The growth in the 3D bioprinting market is fueled by growing adoption of 3D bioprinting technology within the pharmaceutical and cosmetic industries, advancement in the 3D bioprinting technology, rising public and private partnerships and collaborations, increasing investments in R&D and the expenditure on medical devices.

 

Related Reports:

3D Printing Medical Devices Market – Global Forecast to 2028

3D Cell Culture Market – Global Forecast to 2030

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com